ACTRN12611001090909已完成未知
Safety and immunogenicity of inactivated vero-cell-derived Japanese encephalitis vaccine in military personnel previously vaccinated with inactivated mouse-brain-derived JE vaccine.
Csongor Oltvolgyi0 个研究点目标入组 150 人开始时间: 2011年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •1) Previous MBDV vaccinee, due for boosting (3-5 years post last dose).
- •2) Volunteer in 'short-notice-to-move' military unit which requires currency with JE vaccination.
排除标准
- •1) Pregnancy
- •2) Lactation
- •3) Administration of any vaccine 30 days prior to VCDV administration
- •4) Serious ADR to a previous vaccine
- •5) Acute febrile illness
- •6) Known or suspected immune deficiency
研究者
相似试验
已完成
4 期
Immunogenicity of inactivated vero cell culture-derived Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantatioJapanese encephalitisJapanese encephalitis vaccineHematopoietic stem cell transplantationTCTR20191104001Faculty of Medicine Ramathibodi Hospital, Mahidol University37
进行中（未招募）
不适用
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route)EUCTR2008-000943-33-GBSanofi Pasteur SA
进行中（未招募）
不适用
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)Vaccination of healthy subjects aged 18 to 60 years (i.e. to the day before the 61st birthday) or 61 years or above (from the day of the 61st birthday) on the day of inclusion with one dose of the new formulation of the influenza vaccine for the 2007-2008 Northern Hemisphere season.EUCTR2007-000752-14-GBSanofi Pasteur SA
进行中（未招募）
1 期
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route) - N/AEUCTR2006-000671-15-GBSanofi Pasteur SA120
尚未招募
1 期
CENTAURO-6 StudyLiver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000237Center for Genetic Engineering and Biotechnology (CIGB), in Havana.20